Vivos Therapeutics 

$0.186400
29
+$0.01+6.76% Friday 20:00
-$0.01-3.59%Friday 23:59After hours

Statistics

Day High
0.1878
Day Low
0.1859
52W High
4.41
52W Low
0.158
Volume
68,935
Avg. Volume
-
Mkt Cap
3.75M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18NovExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.66
-0.54
-0.43
-0.31
Expected EPS
-0.32
Actual EPS
N/A

Financials

-121.37%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
17.44MRevenue
-21.17MNet Income

Analyst Ratings

2.80Average Price Target
The highest estimate is 3.10.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VVOS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Align Technology
ALGN
Mkt Cap11.19B
Align Technology is a direct competitor in the orthodontic market, offering clear aligner therapies that compete with Vivos' sleep apnea and orthodontic treatments.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation, through its dental segment, offers a range of products that compete with Vivos' solutions in the dental and orthodontic market.
DENTSPLY Sirona
XRAY
Mkt Cap2.22B
Dentsply Sirona is a competitor in the dental supplies and equipment market, offering products that can be used in orthodontic and sleep apnea treatments.
Henry Schein
HSIC
Mkt Cap9.98B
Henry Schein is a distributor of healthcare products and services, including dental products that compete with Vivos Therapeutics' offerings.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. competes in the healthcare market by providing solutions that can overlap with Vivos' treatments in orthopedics and dental health.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation is a medical technology company that, while focusing on orthopedic products, competes in the broader healthcare market against Vivos Therapeutics.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc offers medical devices and therapies that compete with Vivos Therapeutics in areas such as sleep apnea treatment and healthcare solutions.
Globus Medical
GMED
Mkt Cap11.14B
Globus Medical is involved in musculoskeletal solutions, indirectly competing with Vivos by offering treatments that can affect patients' overall health, including aspects of sleep and orthopedic health.

About

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Show more...
CEO
R. Kirk Huntsman
Employees
268
Country
United States
ISIN
US92859E2072

Listings

0 Comments

Share your thoughts

FAQ

What is Vivos Therapeutics stock price today?
The current price of VVOS is $0.19 USD — it has increased by +6.76% in the past 24 hours. Watch Vivos Therapeutics stock price performance more closely on the chart.
What is Vivos Therapeutics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Vivos Therapeutics stocks are traded under the ticker VVOS.
Is Vivos Therapeutics stock price growing?
VVOS stock has fallen by -17.12% compared to the previous week, the month change is a -45.27% fall, over the last year Vivos Therapeutics has showed a -95.48% decrease.
What is Vivos Therapeutics market cap?
Today Vivos Therapeutics has the market capitalization of 3.75M
When is the next Vivos Therapeutics earnings date?
Vivos Therapeutics is going to release the next earnings report on November 18, 2026.
What were Vivos Therapeutics earnings last quarter?
VVOS earnings for the last quarter are -0.31 USD per share, whereas the estimation was -0.41 USD resulting in a +24.39% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Vivos Therapeutics revenue for the last year?
Vivos Therapeutics revenue for the last year amounts to 17.44M USD.
What is Vivos Therapeutics net income for the last year?
VVOS net income for the last year is -21.17M USD.
How many employees does Vivos Therapeutics have?
As of September 05, 2026, the company has 268 employees.
In which sector is Vivos Therapeutics located?
Vivos Therapeutics operates in the Health & Wellness sector.
When did Vivos Therapeutics complete a stock split?
The last stock split for Vivos Therapeutics was on October 27, 2023 with a ratio of 1:25.
Where is Vivos Therapeutics headquartered?
Vivos Therapeutics is headquartered in LITTLETON, United States.